• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MTCH2通过PI3K/Akt信号通路刺激乳腺癌细胞的增殖和细胞周期。

MTCH2 stimulates cellular proliferation and cycles via PI3K/Akt pathway in breast cancer.

作者信息

Jiang Wenying, Miao Yuxia, Xing Xiaoxiao, Liu Shuiqing, Xing Wei, Qian Feng

机构信息

Department of Radiology, The Third Affiliated Hospital of Soochow University, Changzhou, 213000, China.

Department of Breast Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, 213000, China.

出版信息

Heliyon. 2024 Mar 19;10(6):e28172. doi: 10.1016/j.heliyon.2024.e28172. eCollection 2024 Mar 30.

DOI:10.1016/j.heliyon.2024.e28172
PMID:38560664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10979243/
Abstract

The MTCH2 protein is located on the mitochondrial outer membrane and regulates mitochondria-related cell death. This study set out to investigate the role of MTCH2 in the underlying pathophysiological mechanisms of breast cancer (BC). MTCH2 expression levels in BC were analyzed using bioinformatics prior to verification by cell lines in vitro. Experiments of over-expression and siRNA-mediated knockdown of MTCH2 were conducted to assess its biological functions, including its effects on cellular proliferation and cycle progression. Xenografts were utilised for study and signaling pathway alterations were examined to identify the mechanisms driven by MTCH2 in BC proliferation and cell-cycle regulation. MTCH2 was up-regulated in BC and correlated with patients' overall survival. Over-expression of MTCH2 promoted cellular proliferation and cycle progression, while silencing MTCH2 had the opposite effect. Xenograft experiments were utilised to confirm the in vitro cellular findings and it was identified that the PI3K/Akt signaling pathway was activated by MTCH2 over-expression and suppressed by its silencing. Moreover, the activation of IGF-1R rescued cellular growth and cycle arrest induced by MTCH2-silencing. Overall, this study reveals that expression of MTCH2 in BC is upregulated and potentiates cellular proliferation and cycle progression via the PI3K/Akt pathway.

摘要

MTCH2蛋白位于线粒体外膜,调节与线粒体相关的细胞死亡。本研究旨在探讨MTCH2在乳腺癌(BC)潜在病理生理机制中的作用。在通过体外细胞系验证之前,利用生物信息学分析了BC中MTCH2的表达水平。进行了MTCH2过表达和siRNA介导的敲低实验,以评估其生物学功能,包括对细胞增殖和细胞周期进程的影响。利用异种移植进行研究,并检测信号通路改变,以确定MTCH2在BC增殖和细胞周期调节中所驱动的机制。MTCH2在BC中上调,且与患者的总生存期相关。MTCH2过表达促进细胞增殖和细胞周期进程,而沉默MTCH2则产生相反的效果。利用异种移植实验证实了体外细胞实验结果,并且发现PI3K/Akt信号通路被MTCH2过表达激活,被其沉默所抑制。此外,IGF-1R的激活挽救了由MTCH2沉默诱导的细胞生长和细胞周期停滞。总体而言,本研究表明MTCH2在BC中的表达上调,并通过PI3K/Akt途径增强细胞增殖和细胞周期进程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/995e7479ac3a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/420756e6f400/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/c6d73b0dd085/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/3bc818538376/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/d03aa92fc17d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/30a4aff2d939/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/995e7479ac3a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/420756e6f400/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/c6d73b0dd085/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/3bc818538376/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/d03aa92fc17d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/30a4aff2d939/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7c/10979243/995e7479ac3a/gr6.jpg

相似文献

1
MTCH2 stimulates cellular proliferation and cycles via PI3K/Akt pathway in breast cancer.MTCH2通过PI3K/Akt信号通路刺激乳腺癌细胞的增殖和细胞周期。
Heliyon. 2024 Mar 19;10(6):e28172. doi: 10.1016/j.heliyon.2024.e28172. eCollection 2024 Mar 30.
2
Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma.抑制线粒体载体家族 2 蛋白(MTCH2)可抑制恶性脑胶质瘤的侵袭,并增强替莫唑胺的敏感性。
Mol Med. 2021 Jan 28;27(1):7. doi: 10.1186/s10020-020-00261-4.
3
miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.微小RNA-489通过靶向SPIN1介导的PI3K/AKT信号通路抑制胶质瘤细胞的增殖、细胞周期进程并诱导其凋亡。
Biomed Pharmacother. 2017 Sep;93:435-443. doi: 10.1016/j.biopha.2017.06.058. Epub 2017 Jun 27.
4
Curcumol inhibits breast cancer growth NCL/ERα36 and the PI3K/AKT pathway.姜黄素抑制乳腺癌生长 NCL/ERα36 和 PI3K/AKT 通路。
Food Funct. 2023 Jan 23;14(2):874-885. doi: 10.1039/d2fo02387c.
5
AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.醛酮还原酶1B10通过PI3K/AKT/NF-κB信号通路促进乳腺癌细胞的增殖和迁移。
Cell Biosci. 2021 Aug 21;11(1):163. doi: 10.1186/s13578-021-00677-3.
6
The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.胰岛素样生长因子-1受体及其信号通路在乳腺癌干细胞/祖细胞中的表达及意义
Breast Cancer Res. 2013 May 12;15(3):R39. doi: 10.1186/bcr3423.
7
KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer PI3K/AKT/mTOR Signaling Pathway.驱动蛋白家族成员C3(KIFC3)通过PI3K/AKT/mTOR信号通路促进结直肠癌的增殖、迁移和侵袭。
Front Genet. 2022 Jun 22;13:848926. doi: 10.3389/fgene.2022.848926. eCollection 2022.
8
Oxypalmatine regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids.氧化吴茱萸碱通过抑制 PI3K/AKT 信号通路调节乳腺癌细胞的增殖和凋亡及其对乳腺癌类器官的疗效。
Phytomedicine. 2023 Jun;114:154752. doi: 10.1016/j.phymed.2023.154752. Epub 2023 Mar 10.
9
MTCH2 promotes the malignant progression of ovarian cancer through the upregulation of AIMP2 expression levels, mitochondrial dysfunction and by mediating energy metabolism.MTCH2通过上调AIMP2表达水平、导致线粒体功能障碍以及介导能量代谢来促进卵巢癌的恶性进展。
Oncol Lett. 2024 Aug 12;28(4):492. doi: 10.3892/ol.2024.14625. eCollection 2024 Oct.
10
Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.Hsa_circ_001569 是一个不利的预后因素,通过调节乳腺癌中的 PI3K-AKT 通路促进细胞增殖和转移。
Cancer Biomark. 2019;25(2):193-201. doi: 10.3233/CBM-182293.

引用本文的文献

1
MTCH2 regulates NRF2-mediated RRM1 expression to promote melanoma proliferation and dacarbazine insensitivity.MTCH2调节NRF2介导的RRM1表达,以促进黑色素瘤增殖和对达卡巴嗪不敏感。
Cell Death Dis. 2025 Apr 9;16(1):268. doi: 10.1038/s41419-025-07618-9.
2
Mitochondrial carrier homolog 2 is important for mitochondrial functionality and non-small cell lung cancer cell growth.线粒体载体同源物2对线粒体功能和非小细胞肺癌细胞生长很重要。
Cell Death Dis. 2025 Feb 13;16(1):95. doi: 10.1038/s41419-025-07419-0.
3
Identification of mitochondrial carrier homolog 2 as an important therapeutic target of castration-resistant prostate cancer.

本文引用的文献

1
MTCH2 is a mitochondrial outer membrane protein insertase.MTCH2 是一种线粒体外膜蛋白插入酶。
Science. 2022 Oct 21;378(6617):317-322. doi: 10.1126/science.add1856. Epub 2022 Oct 20.
2
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance.乳腺癌中的 PI3K 抑制:识别和克服不同类型的耐药性。
Crit Rev Oncol Hematol. 2021 Jun;162:103334. doi: 10.1016/j.critrevonc.2021.103334. Epub 2021 Apr 15.
3
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
鉴定线粒体载体同源物2为去势抵抗性前列腺癌的重要治疗靶点。
Cell Death Dis. 2025 Feb 5;16(1):70. doi: 10.1038/s41419-025-07406-5.
4
The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives.线粒体溶质载体SLC25在癌症代谢重编程中的作用:当前见解与未来展望
Int J Mol Sci. 2024 Dec 26;26(1):92. doi: 10.3390/ijms26010092.
5
Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth.靶向 POLRMT 通过 IMT1 抑制结直肠癌细胞生长。
Cell Death Dis. 2024 Sep 3;15(9):643. doi: 10.1038/s41419-024-07023-8.
阿培利司联合氟维司群治疗 CDK4/6 抑制剂治疗后 PI3KCA 突变、激素受体阳性的晚期乳腺癌(BYLieve):一项多中心、开放标签、非对照、2 期研究的一个队列。
Lancet Oncol. 2021 Apr;22(4):489-498. doi: 10.1016/S1470-2045(21)00034-6.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma.抑制线粒体载体家族 2 蛋白(MTCH2)可抑制恶性脑胶质瘤的侵袭,并增强替莫唑胺的敏感性。
Mol Med. 2021 Jan 28;27(1):7. doi: 10.1186/s10020-020-00261-4.
6
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
7
Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases.胰岛素样生长因子-1 在骨骼肌及多种疾病中的意义。
Cells. 2020 Jul 24;9(8):1773. doi: 10.3390/cells9081773.
8
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors.伊帕替膦联合化疗治疗实体瘤的抗肿瘤活性:Ib 期研究结果。
Ann Oncol. 2020 May;31(5):626-633. doi: 10.1016/j.annonc.2020.02.007. Epub 2020 Feb 20.
9
Cops5 safeguards genomic stability of embryonic stem cells through regulating cellular metabolism and DNA repair.Cops5 通过调节细胞代谢和 DNA 修复来保障胚胎干细胞的基因组稳定性。
Proc Natl Acad Sci U S A. 2020 Feb 4;117(5):2519-2525. doi: 10.1073/pnas.1915079117. Epub 2020 Jan 21.
10
Breast cancer.乳腺癌。
Nat Rev Dis Primers. 2019 Sep 23;5(1):66. doi: 10.1038/s41572-019-0111-2.